Medrol and pneumocystis jiroveci infection Patient Reports March 20, 2010

Medrol Side Effects Report #4623452-0
Medrol side effect was reported by a Physician from on Mar 17, 2005. Male patient, 33 years of age, weighting 158.7 lb, was diagnosed with intracranial pressure increased, ill-defined disorder and was treated with Medrol. After drug was administered, patient experienced the following side effects: pneumocystis jiroveci infection, pyrexia, unevaluable event. Medrol dosage: 200 MG (100 MG, 2 IN 1 D), ORAL. During the same period patient was treated with TEMOZOLOMIDE, ERGENYL CHRONO, ALPRAZOLAM, PAROXETINE. Patient was hospitalized. Patient recovered.

Medrol Side Effects Report #4627331-4
Medrol side effect was reported by a Pharmacist from on Mar 18, 2005. Male patient, 33 years of age, weighting 158.7 lb, was diagnosed with intracranial pressure increased, oligodendroglioma and was treated with Medrol. After drug was administered, patient experienced the following side effects: epilepsy , pneumocystis jiroveci infection. Medrol dosage: 200 MG (100 MG, 2 IN 1 D). During the same period patient was treated with TEMOZOLOMIDE, ALPRAZOLAM, PAROXETINE, ERGENYL CHRONO. Patient was hospitalized. Patient recovered.

Medrol Side Effects Report #4635538-5
Medrol side effect was reported by a Pharmacist from on Apr 01, 2005. Male patient, 33 years of age, weighting 158.7 lb, was diagnosed with intracranial pressure increased, oligodendroglioma and was treated with Medrol. After drug was administered, patient experienced the following side effects: epilepsy , pneumocystis jiroveci infection. Medrol dosage: 200 MG (100 MG, 2 IN 1 D), ORAL. During the same period patient was treated with TEMOZOLOMIDE, ALPRAZOLAM, PAROXETINE, ERGENYL CHRONO. Patient was hospitalized. Patient recovered.

Medrol Side Effects Report #4576327-X
Medrol side effect was reported by a Physician from on Jan 24, 2005. Female patient, 53 years of age, was diagnosed with ill-defined disorder and was treated with Medrol. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, diabetes mellitus inadequate control, iatrogenic injury, interstitial lung disease, pneumocystis jiroveci infection, respiratory failure. Medrol dosage: 64 MG (32 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ACETYLCYSTEINE, LAMOTRIGINE, CLOBAZAM, OMEPRAZOLE. Patient died on 07/09/2003.


Medrol Side Effects Report #4600663-1
Medrol side effect was reported by a Physician from on Feb 17, 2005. Female patient, 53 years of age, was diagnosed with ill-defined disorder and was treated with Medrol. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, condition aggravated, diabetes mellitus, iatrogenic injury, infection in an immunocompromised host, interstitial lung disease, pneumocystis jiroveci infection, respiratory failure. Medrol dosage: 64 MG (32 MG, INTERVAL: EVERY DAY), ORAL. During the same period patient was treated with ACETYLCYSTEINE, LAMOTRIGINE, CLOBAZAM, OMEPRAZOLE. Patient died on 07/09/2003.